🔗 Permalink

Inventor profile of:

Manfred Keller

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2022-01-27

Top Assignees for applications by Manfred Keller

The entities that hold a legal rights for patent applications filed by inventor Keller Manfred:

PARI Pharma GmbH 8 Starnberg, Germany
Patara Pharma, LLC 5 San Diego, CA United States
POLYPHOR AG 3 Allschwil, Switzerland
Respivant Sciences GmbH 2 Basel, Switzerland
KAMADA LTD. 2 Ness-Ziona, Israel
Respivant Services GmbH 1 Basel, Switzerland
Pari GmbH 1 Starnberg, Germany
PARI Pharma GmbH 1 Munich, Germany
Meiji Seika Pharma Co., Ltd. 1 Tokyo, Japan

Recent patent applications by Keller Manfred

Manfred Keller from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-01-27

US20220023379A1

Human necessities

Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

#2 | 2020-07-23

US20200230203A1

Human necessities

Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

#3 | 2020-07-23

US20200230202A1

Human necessities

Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

#4 | 2019-12-26

US20190388386A1

Human necessities

MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS

#5 | 2019-10-31

US20190328700A1

Human necessities

Methods of treating respiratory syncytial virus infections

#6 | 2019-06-13

US20190175546A1

Human necessities

Mast cell stabilizers treatment for systemic disorders

#7 | 2018-09-27

US20180271828A1

Human necessities

Mast cell stabilizers treatment for systemic disorders

#8 | 2017-09-28

US20170273941A1

Human necessities

Mast cell stabilizers treatment for systemic disorders

#9 | 2016-12-22

US20160367520A1

Human necessities

MAST CELL STABILIZERS FOR LUNG DISEASE TREATMENT

#10 | 2016-12-22

US20160367519A1

Human necessities

Mast cell stabilizers treatment for systemic disorders

#11 | 2016-12-01

US20160346246A1

Human necessities

METHODS FOR THE TREATMENT OF LUNG DISEASES WITH MAST CELL STABILIZERS

#12 | 2016-12-01

US20160346245A1

Human necessities

Mast cell stabilizers treatment for systemic disorders

#13 | 2015-10-22

US20150297557A1

Human necessities

Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

#14 | 2015-08-13

US20150224078A1

Human necessities

Methods for the Treatment of Lung Diseases with Mast Cell Stabilizers

#15 | 2015-08-13

US20150224077A1

Human necessities

Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders

#16 | 2014-12-18

US20140366872A1

Human necessities

Aerosols for sinunasal drug delivery

#17 | 2014-11-20

US20140343005A1

Human necessities

Aqueous compositions comprising arbekacin

#18 | 2013-07-11

US20130177626A1

Human necessities

Pharmaceutical compositions comprising cyclosporin

#19 | 2012-08-23

US20120211005A1

Human necessities

PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR

#20 | 2010-12-16

US20100316576A1

Human necessities

Aerosols for sinunasal drug delivery

#21 | 2009-12-10

US20090304604A1

Human necessities

PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR

#22 | 2009-09-17

US20090232744A1

Human necessities

Macrolide compositions having improved taste and stability

#23 | 2009-07-02

US20090169607A1

Human necessities

Pharmaceutical compositions comprising cyclosporin

#24 | 2009-05-07

US20090118249A1

Human necessities

DHEAS INHALATION COMPOSITIONS

#25 | 2007-08-23

US20070193577A1

Human necessities

Disodium cromoglycate compositions and methods for administering same

#26 | 2007-03-29

US20070071686A1

Human necessities

Liquid preparation containing tobramycin

InventorID:

334292 ⎘